Menu
Recruiting NCT07735403

Dozee Validation for Contactless Heart Rate and Respiration Monitoring in Clinical Settings

Observational No Specific Medical Conditions or Disease States

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Telemetry monitoring.
Who it may be relevant to
Registry conditions: No Specific Medical Conditions or Disease States. Basic parameters: 22 years — 100 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Dozee System Validation for Contactless Heart Rate and Respiration Monitoring in Clinical Settings

Overview

The Dozee VS system (K221555) is a contactless device that tracks heart rate and breathing rate using a sensor sheet placed under the mattress. It captures body vibrations and converts them into vital signs, which can be monitored remotely in real time. The system also supports add-ons like a blood pressure cuff, pulse oximeter, and thermometer, offering a complete monitoring solution. This study aims to validate the updated AI-powered heart rate and improved breathing rate algorithms across different sensor sheet types to confirm clinical accuracy

Detailed description

The Dozee VS system (K221555), developed by Turtle Shell Technologies, is a non-invasive, contactless device that continuously monitors heart rate (HR) and breathing rate (RR). A thin sensor sheet placed under the mattress detects tiny body vibrations from the heart and lungs, which are processed by smart algorithms and displayed on a secure online dashboard for real-time monitoring.Unlike traditional methods such as ECGs, nasal tubes, or thermistors-which are invasive, require skilled placement, and are uncomfortable for long-term use-Dozee is simple, comfortable, and doesn't rely on patient compliance like wearables do. The system can also connect to add-on devices, including a blood pressure cuff, pulse oximeter, and thermometer, giving a full picture of a patient's vital signs and helping spot early signs of deterioration. Hardware upgrades now include dual-sensor sheets that improve accuracy across different mattresses and patient types. The new HR algorithm uses AI/ML for better accuracy, while the improved RR algorithm performs more reliably even with movement or weak signals.Study Goal: This study aims to validate the updated algorithms (Gen 2) for HR and RR across the three sensor sheet types (DS, S1, and S1-I) to ensure they meet clinical accuracy standards

Interventions

  • Device Telemetry monitoring
    All participants will be on standard telemetry monitoring for Heart Rate, Respiration Rate and movements using the gold standard (Electrocardiography and Capnography respectively)

Primary outcome measures

  • Mean Absolute Error (MAE) of Dozee's Heart Rate a from the Gold Standard ECG [Time frame: 6 months]
  • Mean Absolute Error (MAE) of Dozee's Respiratory Rate from the Gold Standard Capnography [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • Adults Male or female. (≥ 22 years of age)
  • Provide written informed consent.
  • Weight over 40kg/88.18lbs

Exclusion criteria

  • Are connected to a device that may interfere with the device monitoring in this study.
  • Are receiving any bedside care which may be incompatible with the study procedures.
  • A likely need to receive or undergo a procedure during the testing period.
  • Cannot accept a nasal cannula, or have an ECG leads placed on the chest.
  • Have a significant medical condition in the judgement of the investigator, which may compromise the study testing procedures.
  • Prisoners

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Oak Village Healthcare — Lake Jackson

Identifiers

NCT: NCT07735403 · DZ_VS_VAL_ON

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗